Novo Nordisk A/S ADR buy fenjal
Start price
09.05.17
/
50%
€37.03
Target price
18.09.17
€42.00
Performance (%)
10.53%
End price
18.09.17
€40.52
Summary
This prediction ended on 18.09.17 with a price of €40.52. The prediction had a final performance of 10.53%. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S ADR | -3.306% | -3.306% | -18.467% | 51.163% |
iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
According to fenjal what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by fenjal for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
fenjal stimmt dem Sentiment von 'Buy' zu
fenjal stimmt am 09.05.2017 dem Buy-Gesamtsentiment mit dem Kursziel 49.6€ zu.
(Vom Mitglied beendet)
Stopped prediction by fenjal for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€154.00
29.05.23
29.05.23
-
29.05.24
29.05.24
10.06%
16.08.23
16.08.23
Could be worthwhile Investment >10% per year